−0.46CNY
−370.55 MCNY
687.72 MCNY
581.97 M
About HYBIO PHARMACEUTIC
Sector
CEO
Yu Pin Xiang
Headquarters
Shenzhen
Website
Employees (FY)
975
Founded
2003
ISIN
CNE1000011T7
FIGI
BBG001F74L77
Hybio Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sales of chemically synthesized peptide drugs. It offers Desmopressin acetate injection, Thymopentin, Somatostatin, Terlipressin, and Carbetocin for Injection. It focuses on building a digitalized chronic diseases management platform with the combination of drugs, medical instruments, and Internet. The company was founded on April 2, 2003 and is headquartered in Shenzhen, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 300199 is 12.94 CNY — it has increased by 3.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange HYBIO PHARMACEUTIC stocks are traded under the ticker 300199.
HYBIO PHARMACEUTIC is going to release the next earnings report on Apr 27, 2024. Keep track of upcoming events with our Earnings Calendar.
300199 stock is 6.24% volatile and has beta coefficient of 1.62. Check out the list of the most volatile stocks — is HYBIO PHARMACEUTIC there?
Yes, you can track HYBIO PHARMACEUTIC financials in yearly and quarterly reports right on TradingView.
300199 stock has risen by 12.13% compared to the previous week, the month change is a 4.86% rise, over the last year HYBIO PHARMACEUTIC has showed a 23.71% increase.
Today HYBIO PHARMACEUTIC has the market capitalization of 11.03 B, it has increased by 10.26% over the last week.
Like other stocks, 300199 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HYBIO PHARMACEUTIC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 975.00 employees. See our rating of the largest employees — is HYBIO PHARMACEUTIC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HYBIO PHARMACEUTIC technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HYBIO PHARMACEUTIC stock shows the buy signal. See more of HYBIO PHARMACEUTIC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.